Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Abliva AB logo — Delivering mitochondrial health

Abliva AB

Delivering mitochondrial health

Founded 2000 Sweden Sweden 12 employees Post Ipo Equity Total: $264.05M Biotechnology, Health Care

General Information

Company Name Abliva AB
Founded Year 2000
Location Sweden Sweden +1
Founders / Decision Makers
Ellen Wittmack Donnelly — CEO Catharina Jz. Johansson — CFO Eleonor Åsander Frostner — R&D / Communications
Employees 12
Industries Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when Abliva AB moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Abliva AB

Abliva AB is a Swedish biotechnology company founded in 2000 with a mission to enhance mitochondrial health. Specializing in the development of medicines for mitochondrial diseases, Abliva focuses on addressing rare and severe conditions resulting from dysfunctional mitochondria, the cell's energy source. Abliva's pipeline includes two key projects: KL1333, a late-stage development drug that regulates essential co-enzymes NAD⁺ and NADH, and NV354, an energy replacement therapy in preclinical development. The company’s dedication to groundbreaking research and development has attracted significant investment, including a kr200.00M post-IPO equity investment on 31 May 2022 from IP Group. Abliva's listing on Nasdaq Stockholm (ticker: ABLI) underlines its commitment to driving innovation in the biotechnology and healthcare industries from its base in Lund, Sweden. With a focus on addressing critical unmet medical needs, Abliva is poised to make a significant impact in the field of mitochondrial health.

Taxonomy: Mitochondrial medicine, Mitochondrial disorders, NAD⁺, NADH, Energy replacement therapy, Rare diseases, Late-stage development, Preclinical development, Pharmaceuticals, Nasdaq Stockholm, Swedish biotech company

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity kr200.00M 1
IP Group
31 May 2022
Post-IPO Equity kr20.00M 1
Hadean Partners
22 Apr 2020
Post-IPO Equity kr28.20M 1
Nyenburgh Investment Partners
07 Mar 2019
Grant $4.09M 2
Congressionally Directed Medical Research Programs
U.S. Department of Defense 		29 Aug 2018
Grant kr1.00M 1
Vinnova
07 Jun 2017

View All 7 Funding Rounds

Abliva AB Alternatives & Competitors

Abliva AB vs
Pretzel Therapeutics
Pretzel Therapeutics United States

Welcome to a new era in mitochondrial therapeutics

Series A
46 employees
Biotechnology, Health and Wellness
Abliva AB vs
MitoPower
MitoPower United States

Therapeutics for patients with severe mitochondrial dysfunction

5 employees
Biopharma, Biotechnology
Abliva AB vs
Ixchel Pharma
Ixchel Pharma

Pioneering the future of treatments for rare mitochondrial diseases with repurposed drug solutions.

2-10 employees
Pharmaceutical

FAQ About Abliva AB

Delivering mitochondrial health
Abliva AB was founded in 2000.
Abliva AB is headquartered in Sweden.
Abliva AB operates in the following industries: Biotechnology, Health Care.
Abliva AB has approximately 12 employees.
Abliva AB has completed 7 funding rounds, raising a total of $264.05M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Abliva AB include Pretzel Therapeutics, MitoPower, Ixchel Pharma, Minovia Therapeutics , Retrotope. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Abliva AB and Pretzel Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Abliva AB and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy